Search by Drug Name or NDC

    NDC 00363-0875-36 Walgreens Effervescent Cold Relief Plus 325; 2; 7.8 mg/1; mg/1; mg/1 Details

    Walgreens Effervescent Cold Relief Plus 325; 2; 7.8 mg/1; mg/1; mg/1

    Walgreens Effervescent Cold Relief Plus is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreens. The primary component is ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE.

    Product Information

    NDC 00363-0875
    Product ID 0363-0875_e0544e9f-93c0-62a1-e053-2995a90aa1a3
    Associated GPIs 43994003080830
    GCN Sequence Number 065743
    GCN Sequence Number Description chlorphenir/phenyleph/aspirin TABLET EFF 2-7.8-325 ORAL
    HIC3 B5N
    HIC3 Description 1ST GEN ANTIHIST-DECON-ANALGESIC, SALICYLATE
    GCN 27781
    HICL Sequence Number 036694
    HICL Sequence Number Description CHLORPHENIRAMINE MALEATE/PHENYLEPHRINE BITARTRATE/ASPIRIN
    Brand/Generic Generic
    Proprietary Name Walgreens Effervescent Cold Relief Plus
    Proprietary Name Suffix n/a
    Non-Proprietary Name Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EFFERVESCENT
    Route ORAL
    Active Ingredient Strength 325; 2; 7.8
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE
    Labeler Name Walgreens
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor An
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00363-0875-36 (00363087536)

    NDC Package Code 0363-0875-36
    Billing NDC 00363087536
    Package 18 POUCH in 1 CARTON (0363-0875-36) / 2 TABLET, EFFERVESCENT in 1 POUCH
    Marketing Start Date 2022-01-18
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL b60e2cf9-11ec-469e-e053-2a95a90a712a Details

    Revised: 5/2022